Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26942445)

Published in PLoS One on March 04, 2016

Authors

Anne Christin Meyer-Gerspach1, Lucian Cajacob1, Daniele Riva1, Raphael Herzog1, Juergen Drewe1, Christoph Beglinger1, Bettina K Wölnerhanssen1

Author Affiliations

1: Department of Biomedicine, Division of Gastroenterology, University Hospital Basel, Basel, Switzerland.

Associated clinical trials:

Oral Glucose Stimulation in Normal-weight and Obese Volunteers | NCT01875575

Articles cited by this

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr (1978) 6.49

Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology (1993) 4.14

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest (1988) 2.93

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab (1986) 2.80

What is the best predictor of future type 2 diabetes? Diabetes Care (2007) 2.64

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev (2007) 2.51

C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes (1984) 2.12

Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest (1996) 2.10

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction. Int J Obes Relat Metab Disord (2001) 2.05

Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology (2014) 1.93

Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab (2011) 1.90

Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia (1993) 1.80

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg (2012) 1.71

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut (2005) 1.53

Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39

Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol (1982) 1.38

Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol (1988) 1.25

The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut (2000) 1.23

Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab (2007) 1.18

Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying. J Clin Endocrinol Metab (2010) 1.17

Gastric emptying and obesity. Gastroenterology (1983) 1.16

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes Obes Metab (2012) 1.15

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia (2007) 1.13

Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab (2005) 1.13

Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil (2001) 1.10

Regulation of glucagon secretion by incretins. Diabetes Obes Metab (2011) 1.08

Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab (1981) 1.08

Fat in the intestine as a regulator of appetite--role of CCK. Physiol Behav (2004) 1.07

Free fatty acid receptors and their role in regulation of energy metabolism. Rev Physiol Biochem Pharmacol (2013) 1.03

Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond) (2008) 1.03

Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism (1986) 0.97

Gastric and oesophageal emptying in obesity. Scand J Gastroenterol (1989) 0.96

Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes (2014) 0.96

Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab (2004) 0.96

Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol (2000) 0.95

Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord (1996) 0.94

The effect of short-term dietary supplementation with glucose on gastric emptying in humans. Br J Nutr (1991) 0.91

Delayed gastric emptying in the obese: an assessment using the non-invasive (13)C-octanoic acid breath test. Diabetes Obes Metab (2004) 0.91

Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorption. Obesity (Silver Spring) (2014) 0.91

Effect of obesity and major weight reduction on gastric emptying. Int J Obes Relat Metab Disord (2000) 0.88

Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. Peptides (1998) 0.88

Effect of short-term starvation on gastric emptying in humans: relationship to oral glucose tolerance. Am J Physiol (1995) 0.88

Gastric emptying, mouth-to-cecum transit, and glycemic, insulin, incretin, and energy intake responses to a mixed-nutrient liquid in lean, overweight, and obese males. Am J Physiol Endocrinol Metab (2012) 0.85

Gastric and intestinal satiation in obese and normal weight healthy people. Physiol Behav (2014) 0.84

Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil (2009) 0.83

Impact of gastric emptying to the glycemic and insulinemic responses to a 75-g oral glucose load in older subjects with normal and impaired glucose tolerance. Physiol Rep (2014) 0.82

Effect of increasing the caloric/osmotic content of the liquid component of a mixed solid and liquid meal on gastric emptying in obese subjects. Hum Nutr Clin Nutr (1986) 0.81

Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents. Obesity (Silver Spring) (2014) 0.80

Gastric secretion does not affect the reliability of the 13C-acetate breath test: A validation of the 13C-acetate breath test by magnetic resonance imaging. Neurogastroenterol Motil (2012) 0.77

Effects of Fat and Protein Preloads on Pouch Emptying, Intestinal Transit, Glycaemia, Gut Hormones, Glucose Absorption, Blood Pressure and Gastrointestinal Symptoms After Roux-en-Y Gastric Bypass. Obes Surg (2016) 0.76